
Airtec Fb 200 Dpi Cap
Glenmark Pharmaceuticals - Capsule - 30 S
Prescription required
Metformin (500mg) + Miglitol (25mg)
Mignar 25 Mf Tablet is used for mignar25-MF Tablet SR is used in the treatment of type 2 diabetes.
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated September 2026
Mignar 25 Mf Tablet contains Metformin (500mg) + Miglitol (25mg). It belongs to the Biguanide and Oral anti-diabetic class of medicines.
Mignar25-MF Tablet SR is used in the treatment of type 2 diabetes.
Mignar25-MF Tablet SR is a combination of two antidiabetic medicines: Metformin and miglitol. Metformin restores the body's ability to use insulin, reduces glucose absorption from the intestine as well as glucose production in the liver. Miglitol inhibits the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mignar25-MF Tablet SR is to be taken with food.<br/>Mignar25-MF Tablet SR may cause stomach upset if taken on empty stomach.
Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.
Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.
An overdose of this medicine can cause a dangerous build-up of acid in the blood, with vomiting, severe weakness and laboured breathing. It may cause low blood sugar and marked stomach upset. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.
Most side effects of Mignar are mild and settle as the body adjusts. Reported side effects include:
Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.
| Pregnancy | Mignar25-MF Tablet SR is probably safe to use during pregnancy.<br/>Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor. |
|---|---|
| Breastfeeding | Mignar25-MF Tablet SR is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby. |
| Alcohol | Taking miglitol with alcohol may affect blood glucose levels in patients with diabetes. |
| Driving | May cause drowsiness or affect your concentration. Do not drive until you know how it affects you. |
| Kidney | Mignar25-MF Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Mignar25-MF Tablet SR may be needed. Please consult your doctor.<br/>Use of Mignar25-MF Tablet SR is not recommended in patients with severe kidney disease. |
| Liver | Mignar25-MF Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Mignar25-MF Tablet SR may not be needed in these patients. Please consult your doctor. |
| Habit forming | No |
Stomach upset is common in the first two weeks and usually settles; taking it with food helps. Tell your doctor before any surgery or a scan that uses contrast dye — this medicine is usually stopped for a short time around them. Stop and seek urgent care if you develop deep rapid breathing, severe weakness, muscle pain or vomiting with cold clammy skin. This is rare but serious. Long-term use can lower vitamin B12, so your doctor may check it from time to time. If you feel shaky, sweaty, confused or unusually hungry, take sugar, glucose or a sweet drink at once and tell your doctor — these are signs your blood sugar has fallen too low. If a low-sugar episode happens while on an alpha-glucosidase inhibitor such as voglibose or acarbose, use glucose — ordinary sugar and sweets work more slowly. Tell your doctor about any new swelling of the ankles, breathlessness or sudden weight gain.
Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for people with severe kidney disease, severe liver disease, or an acute illness causing dehydration. Not for people who have had diabetic ketoacidosis. Not for type 1 diabetes or for diabetic ketoacidosis. Not for people with heart failure, active bladder cancer or unexplained blood in the urine.
Tell your doctor about water tablets, steroids, and any contrast dye scan. Alcohol increases the risk of the rare acid build-up and should be limited. Low blood sugar is more likely when combined with insulin or a sulfonylurea.
Store below 30°C in the original pack, away from direct sunlight and moisture. Keep out of the reach of children.
<div class="style__desktop-container___1hcBT"><div class="style__desktop-video___2GTR9"><div class="styles__video-img___1rCzR"><div class=""/><div class=""/></div></div><div><div><div><div><div class="ExpertAdviceItem__content___1Djk2"><ul><li>You have been prescribed this combination medicine as it can control blood sugar better than metformin alone.</li> <li>You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Mignar25-MF Tablet SR.</li> <li>Take it with food to lower your chance of having an upset stomach.</li> <li>It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Monitor your blood sugar level regularly </li> <li>Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremor, and anxious feeling.</li> <li>Tell your doctor immediately if you experience any deep or rapid breathing, persistent nausea, vomiting or stomach pain as Mignar25-MF Tablet SR may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood.</li></ul></div></div></div></div></div></div>

Glenmark Pharmaceuticals - Capsule - 30 S
Prescription required

Glenmark Pharmaceuticals - 30 S
Prescription required
Glenmark Pharmaceuticals - 30 S
Prescription required

Glenmark Pharmaceuticals - Capsule - 30 S
Prescription required
Glenmark Pharmaceuticals - Capsule - 50 mg - 30 S
Prescription required

Glenmark Pharmaceuticals - Capsule - 30 S
Prescription required

Glenmark Pharmaceuticals - 120 Mdi - 1
Prescription required

Glenmark Pharmaceuticals - 30 S
Prescription required

Comed Chemicals - Tablet - 15 S
Prescription required

Comed Chemicals - Capsule - 10 S
Prescription required

Zuventus Healthcare Ltd - 30 ml
Prescription required

Galderma India Pvt Ltd - Lotion - 30 ml
Prescription required

Sun Pharma - Tablet - 4 mg - 24 S
Prescription required
Lupin Lab - 3 ml
Prescription required

Olympus - Tablet - 28 S
Prescription required

Comed Chemicals - 10 S
Prescription required

Icon Pharma - 10 mg - 10 S
Prescription required

East West Pharma - Tablet - 10 mg - 10 S
Prescription required
Glenmark Pharmaceuticals - Tablet - 5 mg - 10 S
Prescription required

Micro Labs - Cream - 15 gm - 15 G
Prescription required

Micro Labs - Capsule - 10 S
Prescription required
Walter Bushnel - 10 mg - 10 S
Prescription required

Brinton Pharmaceuticals Pvt Ltd - Cream - 15 G
Prescription required

Abbott Healthcare Pvt Ltd - Vial - 40 mg - Vial
Prescription required
The information on Mignar 25 Mf Tablet is compiled from the manufacturer's prescribing information and the sources below, and is reviewed by a registered medical practitioner. It does not replace advice from your own doctor.